Anti-Hcp1 Monoclonal Antibody Is Protective against Burkholderia pseudomallei Infection via Recognizing Amino Acids at Asp95-Leu114
Pathogens · 2023
DOI: 10.3390/pathogens13010043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2023. Verfasst von Pan Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology and Immunology, College of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical Univ…. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Melioidosis, Antibodies, Monoclonal, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: technological Innovation Capability Improvement Project of Army Medical University, grants from National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Melioidosis, a severe tropical illness caused by Burkholderia pseudomallei, poses significant treatment challenges due to limited therapeutic options and the absence of effective vaccines. The pathogen’s intrinsic resistance to numerous antibiotics and propensity to induce sepsis during acute infections further complicate management strategies. Thus, exploring alternative methods for prevention and treatment is crucial. Monoclonal antibodies (mAbs) have emerged as a promising strategy for the prevention and treatment of infectious diseases. This study focused on generating three mAbs (13F1, 14G11, and 15D9) targeting hemolysin-coregulated protein 1 (Hcp1), a protein involved in the type VI secretion system cluster 1 (T6SS1) of B. pseudomallei. Notably, pretreatment with 13F1 mAb significantly reduced the intracellular survival of B. pseudomallei and inhibited the formation of macrophage-derived multinucleated giant cells (MNGCs). This protective effect was also observed in vivo. We identified a sequence of amino acids (Asp95-Leu114) within Hcp1 as the likely binding site for 13F1 mAb. In summary, our findings reveal that 13F1 mAb counteracts infection by targeting Hcp1, offering potential new targets and insights for melioidosis prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology and Immunology, College of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University), Chongqing 400000, China.
- State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University (Third Military Medical University), Chongqing 400000, China.
ORCID-Profile: Pan Wu
Förderung
- technological Innovation Capability Improvement Project of Army Medical University
- grants from National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Wu, P., Rao, C., Liu, W., Zhang, Z., Nan, D., Chen, J., Wang, M., Wen, Y., Yan, J., Yue, J., Mao, X., & Li, Q. (2023). Anti-Hcp1 Monoclonal Antibody Is Protective against Burkholderia pseudomallei Infection via Recognizing Amino Acids at Asp95-Leu114. Pathogens. https://doi.org/10.3390/pathogens13010043
Vancouver
Wu P, Rao C, Liu W, Zhang Z, Nan D, Chen J, et al. Anti-Hcp1 Monoclonal Antibody Is Protective against Burkholderia pseudomallei Infection via Recognizing Amino Acids at Asp95-Leu114. Pathogens. 2023. doi:10.3390/pathogens13010043
BibTeX
@article{Wu2023,
author = {Wu, Pan and Rao, Chenglong and Liu, Wenzheng and Zhang, Ziyuan and Nan, Dongqi and Chen, Jiangao and Wang, Minyang and Wen, Yuan and Yan, Jingmin and Yue, Juanjuan and Mao, Xuhu and Li, Qian},
title = {Anti-Hcp1 Monoclonal Antibody Is Protective against Burkholderia pseudomallei Infection via Recognizing Amino Acids at Asp95-Leu114},
journal = {Pathogens},
year = {2023},
doi = {10.3390/pathogens13010043}
}
EUVIMED